Xinyue Wang

Years Active: 2024-2024
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Lin-Rui Gao, Xin Li, Xinyue Wang, Yuanzheng Liang, Yunpeng Wu, Xiao-Li Feng, Wei Rao, Xin Liu, Yong-Wen Song, Hui Fang, Bo Chen, Jing Jin, Yue-Ping Liu, Hao Jing, Yuan Tang, Ning-Ning Lu, Shu-Lian Wang, Ye-Xiong Li, Liang Wang, Shu-Nan Qi
Treatment and survival for patients with localized primary ocular adnexal extranodal marginal zone lymphoma. Leukemia 38 (4) (2024)
Lin-Rui Gao, Xin Li, Xinyue Wang, Yuanzheng Liang, Yunpeng Wu, Xiao-Li Feng, Wei Rao, Xin Liu, Yong-Wen Song, Hui Fang, Bo Chen, Jing Jin, Yue-Ping Liu, Hao Jing, Yuan Tang, Ning-Ning Lu, Shu-Lian Wang, Ye-Xiong Li, Liang Wang, Shu-Nan Qi
Treatment and survival for patients with localized primary ocular adnexal extranodal marginal zone lymphoma. Leukemia (2024)
Lin-Rui Gao, Xin Li, Xinyue Wang, Yuanzheng Liang, Yunpeng Wu, Xiao-Li Feng, Wei Rao, Xin Liu, Yong-Wen Song, Hui Fang, Bo Chen, Jing Jin, Yue-Ping Liu, Hao Jing, Yuan Tang, Ning-Ning Lu, Shu-Lian Wang, Ye-Xiong Li, Liang Wang, Shu-Nan Qi
Treatment and survival for patients with localized primary ocular adnexal extranodal marginal zone lymphoma. Leukemia 38 (4) (2024)
Lin-Rui Gao, Xin Li, Xinyue Wang, Yuanzheng Liang, Yunpeng Wu, Xiao-Li Feng, Wei Rao, Xin Liu, Yong-Wen Song, Hui Fang, Bo Chen, Jing Jin, Yue-Ping Liu, Hao Jing, Yuan Tang, Ning-Ning Lu, Shu-Lian Wang, Ye-Xiong Li, Liang Wang, Shu-Nan Qi
Treatment and survival for patients with localized primary ocular adnexal extranodal marginal zone lymphoma. Leukemia 38 (4) (2024)

Xinyue Wang.css-eqlu8i{font-size:small;padding-left:4px;}